Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Satomi Onoue, Shizuo Yamada & Hak-Kim Chan. (2014) Nanodrugs: pharmacokinetics and safety. International Journal of Nanomedicine 9, pages 1025-1037.
Read now
Read now
Rohimah Mohamud, Sue D. Xiang, Cordelia Selomulya, Jennifer M. Rolland, Robyn E. O’Hehir, Charles L. Hardy & Magdalena Plebanski. (2014) The effects of engineered nanoparticles on pulmonary immune homeostasis. Drug Metabolism Reviews 46:2, pages 176-190.
Read now
Read now
Remigius U Agu & Michael I Ugwoke. (2011)
In vitro and in vivo testing methods for respiratory drug delivery. Expert Opinion on Drug Delivery 8:1, pages 57-69.
Read now
Read now
Articles from other publishers (38)
Sayantan Mukherjee, Sylwia Wciślik, Purna Chandra Mishra & Paritosh Chaudhuri. (2024) Nanofluids: Critical issues, economics and sustainability perspectives. Particuology 87, pages 147-172.
Crossref
Crossref
Aaishwarya Deshmukh, Jayvadan Patel, Govind Vyas & Mukesh Patel. 2022. Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems. Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems
365
384
.
Rabia Hamid & Ifrah Manzoor. 2021. Alternative Medicine - Update. Alternative Medicine - Update.
Ziyao Wang, Zifan Liu, Jie Mei, Shanshan Xu & Ying Liu. (2021) The next generation therapy for lung cancer: taking medicine by inhalation. Nanotechnology 32:39, pages 392002.
Crossref
Crossref
Mohamed E. A. Abdelrahim, Haitham Saeed, Hadeer S. Harb & Yasmin M. MadneyMohamed E. A. Abdelrahim, Haitham Saeed, Hadeer S. Harb & Yasmin M. Madney. 2021. Essentials of Aerosol Therapy in Critically ill Patients. Essentials of Aerosol Therapy in Critically ill Patients
195
217
.
Andrew M. Shen & Tamara Minko. (2020) Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery. Journal of Controlled Release 326, pages 222-244.
Crossref
Crossref
Julia Janina Schüer, Christian Wölk, Udo Bakowsky & Shashank Reddy Pinnapireddy. (2020) Comparison of Tanaka lipid mixture with natural surfactant Alveofact to study nanoparticle interactions on Langmuir film balance. Colloids and Surfaces B: Biointerfaces 188, pages 110750.
Crossref
Crossref
Caleb F. Anderson, Maria E. Grimmett, Christopher J. Domalewski & Honggang Cui. (2019) Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. WIREs Nanomedicine and Nanobiotechnology 12:1.
Crossref
Crossref
Liu Yang, Weikai Ji, Jia-nan Huang & Guoying Xu. (2019) An updated review on the influential parameters on thermal conductivity of nano-fluids. Journal of Molecular Liquids 296, pages 111780.
Crossref
Crossref
Imane Himri & Abdelkarim Guaadaoui. 2018. Nanostructures for the Engineering of Cells, Tissues and Organs. Nanostructures for the Engineering of Cells, Tissues and Organs
1
66
.
Mahasweta Das, Mark Howell, Elspeth A. Foran, Rohit Iyre, Shyam S. Mohapatra & Subhra Mohapatra. (2017) Sertoli Cells Loaded with Doxorubicin in Lipid Micelles Reduced Tumor Burden and Dox-Induced Toxicity. Cell Transplantation 26:10, pages 1694-1702.
Crossref
Crossref
Nazende Günday Türeli, Afra Torge, Jenny Juntke, Bianca C. Schwarz, Nicole Schneider-Daum, Akif Emre Türeli, Claus-Michael Lehr & Marc Schneider. (2017) Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections. European Journal of Pharmaceutics and Biopharmaceutics 117, pages 363-371.
Crossref
Crossref
Ruxana T. Sadikot, Arun V. Kolanjiyil, Clement Kleinstreuer & Israel Rubinstein. (2017) Nanomedicine for Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome. Biomedicine Hub 2:2, pages 1-12.
Crossref
Crossref
Sharad Mangal, Wei Gao, Tonglei Li & Qi Zhou. (2017) Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities. Acta Pharmacologica Sinica 38:6, pages 782-797.
Crossref
Crossref
Young H. Lim, Kristin M. Tiemann, David A. Hunstad, Mahmoud Elsabahy & Karen L. Wooley. (2016) Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. WIREs Nanomedicine and Nanobiotechnology 8:6, pages 842-871.
Crossref
Crossref
Hasan Ali & Sandeep Kumar Singh. (2016) Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine. Therapeutic Delivery 7:10, pages 691-709.
Crossref
Crossref
Yi-Cheng Huang, Rou-Ying Li, Jiun-Yu Chen & Jen-Kun Chen. (2016) Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery. Carbohydrate Polymers 138, pages 114-122.
Crossref
Crossref
M. Moreno-Sastre, M. Pastor, C. J. Salomon, A. Esquisabel & J. L. Pedraz. (2015) Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy. Journal of Antimicrobial Chemotherapy 70:11, pages 2945-2955.
Crossref
Crossref
Song Tang, Mao Wang, Kaylyn E. Germ, Hua-Mao Du, Wen-Jie Sun, Wei-Min Gao & Gregory D. Mayer. (2015) Health implications of engineered nanoparticles in infants and children. World Journal of Pediatrics 11:3, pages 197-206.
Crossref
Crossref
John Gar Yan Chan, Jennifer Wong, Qi Tony Zhou, Sharon Shui Yee Leung & Hak-Kim Chan. (2014) Advances in Device and Formulation Technologies for Pulmonary Drug Delivery. AAPS PharmSciTech 15:4, pages 882-897.
Crossref
Crossref
S. Weber, A. Zimmer & J. Pardeike. (2014) Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 86:1, pages 7-22.
Crossref
Crossref
Keiji Hirota, Tadafumi Kawamoto, Takehisa Nakajima, Kimiko Makino & Hiroshi Terada. (2013) Distribution and deposition of respirable PLGA microspheres in lung alveoli. Colloids and Surfaces B: Biointerfaces 105, pages 92-97.
Crossref
Crossref
ADRIANA L. DA SILVA, RAQUEL S. SANTOS, DÉBORA G. XISTO, SILVIA DEL V. ALONSO, MARCELO M. MORALES & PATRICIA R.M. ROCCO. (2013) Nanoparticle-based therapy for respiratory diseases. Anais da Academia Brasileira de Ciências 85:1, pages 137-146.
Crossref
Crossref
Preethi Marimuthu & Andreas G. Schätzlein. 2013. Fundamentals of Pharmaceutical Nanoscience. Fundamentals of Pharmaceutical Nanoscience
301
336
.
M. Dong, T.E. Mürdter, C. Philippi, B. Loretz, U.F. Schaefer, C.-M. Lehr, M. Schwab & S. Ammon-Treiber. (2012) Pulmonary delivery and tissue distribution of aerosolized antisense 2′-O-Methyl RNA containing nanoplexes in the isolated perfused and ventilated rat lung. European Journal of Pharmaceutics and Biopharmaceutics 81:3, pages 478-485.
Crossref
Crossref
Julian Kirch†Christian A. Ruge, Craig Schneider†Justin Hanes & Claus-Michael Lehr*. 2012. Nanostructured Biomaterials for Overcoming Biological Barriers. Nanostructured Biomaterials for Overcoming Biological Barriers
239
272
.
Robert Landsiedel, Eric Fabian, Lan Ma-Hock, Wendel Wohlleben, Karin Wiench, Franz Oesch & Ben van Ravenzwaay. (2012) Toxico-/biokinetics of nanomaterials. Archives of Toxicology 86:7, pages 1021-1060.
Crossref
Crossref
Peter D. Sly & Karen Schüepp. (2012) Nanoparticles and Children's Lungs: is there a need for caution?. Paediatric Respiratory Reviews 13:2, pages 71-72.
Crossref
Crossref
K.L. Ordidge, B.A. Duffy, J.A. Wells, T.L. Kalber, S.M. Janes & M.F. Lythgoe. (2012) Imaging the paediatric lung: what does nanotechnology have to offer?. Paediatric Respiratory Reviews 13:2, pages 84-88.
Crossref
Crossref
Satomi Onoue, Takuya Matsui, Kazuki Kuriyama, Kumiko Ogawa, Yoshiki Kojo, Takahiro Mizumoto, Shin-ichiro Karaki, Atsukazu Kuwahara & Shizuo Yamada. (2012) Inhalable sustained-release formulation of long-acting vasoactive intestinal peptide derivative alleviates acute airway inflammation. Peptides 35:2, pages 182-189.
Crossref
Crossref
Felipe A. Oyarzun‐Ampuero, Jose Brea, Maria I. Loza, Maria J. Alonso & Dolores Torres. (2011) A Potential Nanomedicine Consisting of Heparin‐Loaded Polysaccharide Nanocarriers for the Treatment of Asthma. Macromolecular Bioscience 12:2, pages 176-183.
Crossref
Crossref
Ruxana T. Sadikot. 2012. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases
315
324
.
Jonas Roller, Matthias W. Laschke, Thomas Tschernig, René Schramm, Nils T. Veith, Henrik Thorlacius & Michael D. Menger. (2011) How to detect a dwarf: in vivo imaging of nanoparticles in the lung. Nanomedicine: Nanotechnology, Biology and Medicine 7:6, pages 753-762.
Crossref
Crossref
Moritz Beck-Broichsitter, Thomas Schmehl, Werner Seeger & Tobias Gessler. (2011) Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung Models. Journal of Nanomaterials 2011, pages 1-16.
Crossref
Crossref
M. Harms & C.C. Müller-Goymann. (2011) Solid lipid nanoparticles for drug delivery. Journal of Drug Delivery Science and Technology 21:1, pages 89-99.
Crossref
Crossref
Gur Jai Pal Singh & Guirag Poochikian. 2011. Controlled Pulmonary Drug Delivery. Controlled Pulmonary Drug Delivery
489
527
.
Bo Olsson, Eva Bondesson, Lars Borgström, Staffan Edsbäcker, Stefan Eirefelt, Katarina Ekelund, Lena Gustavsson & Tove Hegelund-Myrbäck. 2011. Controlled Pulmonary Drug Delivery. Controlled Pulmonary Drug Delivery
21
50
.
M. Nassimi, C. Schleh, H.D. Lauenstein, R. Hussein, H.G. Hoymann, W. Koch, G. Pohlmann, N. Krug, K. Sewald, S. Rittinghausen, A. Braun & C. Müller-Goymann. (2010) A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. European Journal of Pharmaceutics and Biopharmaceutics 75:2, pages 107-116.
Crossref
Crossref